ALCON NORDIC A/S

CVR: 15887478

Growing 28% p.a.Medium companyWell-established (34 yrs)Profitable

Secondary names: ALCON DANMARK A/S, CIBA VISION DANMARK A/S

Active

ALCON NORDIC A/S demonstrates a solid financial trajectory with consistent revenue growth, reaching 1.01 billion DKK in 2024, up from 975 million DKK in 2023. Profitability has also improved significantly, with profits rising from 25.5 million DKK in 2023 to 34.4 million DKK in 2024, indicating enhanced operational efficiency and margin improvement. The company's equity has increased substantially, from 94.7 million DKK in 2023 to 129.1 million DKK in 2024, reflecting a strong financial foundation. However, the fluctuating profit margins over the years, particularly the dip in 2022, may warrant attention. Overall, ALCON NORDIC A/S is well-positioned within the medical supplies industry, showcasing growth potential and a strengthening balance sheet.

AI-generated summary

Overview

Company type: A/S; Aktieselskab
Address: Edvard Thomsens Vej 14, 2300 København S; KØBENHAVN; 2300 København S; Find nearby companies
Founded: 8.1.1992

Details

Industry: Engroshandel med læge- og hospitalsartikler; Code: 464620
Employees: 109 employees; 104 FTE; (2018)
Capital: 501.000 kr.

Contact

Advertising protected

Phone: Log in to see
Email: Log in to see

Purpose

Selskabets formål er drive handels-, industri- og finansieringsvirksomhed, herunder produktion, distribution og markedsføring af farmaceutiske, medicinske og tekniske produkter og ydelser, samt anden dertil knyttet virksomhed efter bestyrelsens skøn.